MELOSO BAR - AN OVERVIEW

The introduction of nicotinamide being a nicotine substitution in e-cigarette and smokeless products and solutions represents a major regulatory problem to the FDA. Nicotinamide does not have nicotinic receptor agonist action and is known to act as a sedative at large dosages6. The statements created by Nicotine River, ECBlend, as well as other ven